HomeAbout

TL;DR CNBC


Most people on weight loss drugs are spending less on restaurants and takeout, survey says - TL;DR CNBC

Most people on weight loss drugs are spending less on restaurants and takeout, survey says

Publishing timestamp: 2024-04-20 08:00:01


Summary

A Morgan Stanley survey found that people taking GLP-1 medications are spending less on eating out and ordering takeout, which could impact the bottom lines of some food and restaurant companies. The rising demand for these medications is expected to continue, with the market for GLP-1s projected to be worth $105 billion by 2030. Some companies, like healthier fast-casual restaurants and coffee chains, are better positioned to manage the impact of GLP-1s, while others, like fast-food chains and packaged food companies, may face more pressure.


Sentiment: MIXED

Tickers: CAVASBUXPTLOSGDEOVITLJACKSMPLWENCMGDGE-GBNOVO.B-DKHSYSAMMSSTZNVOBRBRSHAKTAPLLYWING

Keywords: starbucks corpcava group incwendys cosweetgreen inchealth care industrymolson coors beverage conovo nordisk a/sdiageo plcvital farms incpharmaceuticalsbreaking newsmorgan stanleybusinesschipotle mexican grill incboston beer co inclifestyleeli lilly and cosimply good foods cobellring brands incbiotechnologyconstellation brands incbusiness newswingstop incshake shack incportillos inchershey cojack in the box incbiotech and pharmaceuticals

Source: https://www.cnbc.com/2024/04/20/weight-loss-drug-patients-spend-less-on-restaurants-takeout-survey.html


Developed by Leo Phan